Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.WHO warns Zika virus could affect four million people
WHO Director-General Margaret Chan said the spread of the virus had gone from a mild threat to one of alarming proportions. Chan is due to convene an international
WHO Director-General Margaret Chan said the spread of the virus had gone from a mild threat to one of alarming proportions. Chan is due to convene an international
Adzenys XR-ODT is bioequivalent to an earlier approved mixed amphetamine salts extended-release capsule (Adderall XR), which the company claims is one of the most commonly prescribed medications to
A proposed interim analysis of the high C-reactive protein (CRP) subgroup showed that ruxolitinib plus regorafenib did not demonstrate a sufficient level of efficacy to warrant continuation. Incyte
The agency granted the treatment priority review with a Prescription Drug User Free Act action date of 23 July 2016. Bezlotoxumab is also under review by the European
The Virginia Department of Health (VDH) said the adult resident had recently traveled to a country where Zika virus transmission has been reported. The infection was confirmed through
The company said it will discontinue clinical development of the drug in ulcerative colitis (UC). The Origin phase 2a study demonstrated that GLPG1205 did not differentiate from the
Ofev has been recommended for use within the National Health Service (NHS) in England and Wales in adult patients only if the person has moderate disease with a
AstraZeneca, GlaxoSmithKline, and Johnson & Johnson Innovation will provide funding and expertise to the collaboration with Imperial College London, the University of Cambridge and University College London (UCL).
Under the deal, Medigene will get access to the NTAmer technology that has been developed by TCMetrix, a spin-off firm of the Ludwig Institute for Cancer Research in
IX-01, an investigational compound, was originally discovered at Pfizer’s Sandwich research and development site in the UK. Under the randomized, double-blind, placebo controlled phase 2a study, Ixchelsis investigated